{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:32:54Z","timestamp":1791232374373,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T00:00:00Z","timestamp":1646006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T00:00:00Z","timestamp":1646006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>We studied a young woman with atypical diabetes associated with mild intellectual disability, lymphedema distichiasis syndrome (LDS) and polymalformative syndrome including distichiasis. We used different genetic tools to identify causative pathogenic mutations and\/or copy number variations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Although proband\u2019s, diabetes mellitus occurred during childhood, type 1 diabetes was unlikely due to the absence of detectable autoimmunity. DNA microarray analysis first identified a de novo, heterozygous deletion at the chr16q24.2 locus. Previously, thirty-three pathogenic or likely pathogenic deletions encompassing this locus have been reported in patients presenting with intellectual deficiency, obesity and\/or lymphedema but not with diabetes. Of note, the deletion encompassed two topological association domains, whose one included <jats:italic>FOXC2<\/jats:italic> that is known to be linked with LDS. Via whole-exome sequencing, we found a heterozygous, likely pathogenic variant in <jats:italic>WFS1<\/jats:italic> (encoding wolframin endoplasmic reticulum [ER] transmembrane glycoprotein) which was inherited from her father who also had diabetes. <jats:italic>WFS1<\/jats:italic> is known to be involved in monogenic diabetes. We also found a likely pathogenic variant in <jats:italic>USP9X<\/jats:italic> (encoding ubiquitin specific peptidase 9 X-linked) that is involved in X-linked intellectual disability, which was inherited from her mother who had dyscalculia and dyspraxia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our comprehensive genetic analysis suggested that the peculiar phenotypes of our patient were possibly due to the combination of multiple genetic causes including chr16q24.2 deletion, and two likely pathogenic variants in <jats:italic>WFS1<\/jats:italic> and <jats:italic>USP9X<\/jats:italic>.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-022-02248-2","type":"journal-article","created":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T18:05:12Z","timestamp":1646071512000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Compound genetic etiology in a patient with a syndrome including diabetes, intellectual deficiency and distichiasis"],"prefix":"10.1186","volume":"17","author":[{"given":"Lauriane","family":"Le Collen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Delemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Spodenkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Cornillet Lefebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Vaillant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Badreddine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Derhourhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarik Ait","family":"Mouhoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Jouret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Juttet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre Fran\u00e7ois","family":"Souchon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Vaxillaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Froguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Bonnefond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Doco Fenzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,28]]},"reference":[{"key":"2248_CR1","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1210\/jcem.84.4.5612","volume":"84","author":"RJ Mahler","year":"1999","unstructured":"Mahler RJ, Adler ML. Clinical review 102: type 2 diabetes mellitus: update on diagnosis, pathophysiology, and treatment. J Clin Endocrinol Metab. 1999;84:1165\u201371.","journal-title":"J Clin Endocrinol Metab"},{"key":"2248_CR2","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.cmet.2014.12.020","volume":"21","author":"A Bonnefond","year":"2015","unstructured":"Bonnefond A, Froguel P. Rare and common genetic events in type 2 diabetes: what should biologists know? Cell Metab. 2015;21:357\u201368.","journal-title":"Cell Metab"},{"key":"2248_CR3","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/s42255-020-00294-3","volume":"2","author":"A Bonnefond","year":"2020","unstructured":"Bonnefond A, Boissel M, Bolze A, Durand E, Toussaint B, Vaillant E, et al. Pathogenic variants in actionable MODY genes are associated with type 2 diabetes. Nat Metab. 2020;2:1126\u201334.","journal-title":"Nat Metab"},{"key":"2248_CR4","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S2213-8587(18)30052-4","volume":"6","author":"AL Gloyn","year":"2018","unstructured":"Gloyn AL, Drucker DJ. Precision medicine in the management of type 2 diabetes. Lancet Diabetes Endocrinol. 2018;6:891\u2013900.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2248_CR5","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/1753-0407.12446","volume":"8","author":"M Vaxillaire","year":"2016","unstructured":"Vaxillaire M, Froguel P. Monogenic diabetes: Implementation of translational genomic research towards precision medicine. J Diabetes. 2016;8:782\u201395.","journal-title":"J Diabetes"},{"key":"2248_CR6","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00467-015-3142-2","volume":"31","author":"D Bockenhauer","year":"2016","unstructured":"Bockenhauer D, Jaureguiberry G. HNF1B-associated clinical phenotypes: the kidney and beyond. Pediatr Nephrol. 2016;31:707\u201314.","journal-title":"Pediatr Nephrol"},{"key":"2248_CR7","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/ajmg.a.61935","volume":"185","author":"M Wallis","year":"2021","unstructured":"Wallis M, Pope-Couston R, Mansour J, Amor DJ, Tang P, Stock-Myer S. Lymphedema distichiasis syndrome may be caused by FOXC2 promoter-enhancer dissociation and disruption of a topological associated domain. Am J Med Genet A. 2021;185:150\u20136.","journal-title":"Am J Med Genet A"},{"key":"2248_CR8","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.2337\/db13-0571","volume":"62","author":"LL Bonnycastle","year":"2013","unstructured":"Bonnycastle LL, Chines PS, Hara T, Huyghe JR, Swift AJ, Heikinheimo P, et al. Autosomal dominant diabetes arising from a Wolfram syndrome 1 mutation. Diabetes. 2013;62:3943\u201350.","journal-title":"Diabetes"},{"key":"2248_CR9","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.ajhg.2014.02.004","volume":"94","author":"CC Homan","year":"2014","unstructured":"Homan CC, Kumar R, Nguyen LS, Haan E, Raymond FL, Abidi F, et al. Mutations in USP9X are associated with X-linked intellectual disability and disrupt neuronal cell migration and growth. Am J Hum Genet. 2014;94:470\u20138.","journal-title":"Am J Hum Genet"},{"key":"2248_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","volume":"383","author":"MA Atkinson","year":"2014","unstructured":"Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet. 2014;383:69\u201382.","journal-title":"Lancet"},{"key":"2248_CR11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1651-2227.2000.tb01186.x","volume":"89","author":"H Borg","year":"2000","unstructured":"Borg H, Marcus C, Sj\u00f6blad S, Fernlund P, Sundkvist G. Islet cell antibody frequency differs from that of glutamic acid decarboxylase antibodies\/IA2 antibodies after diagnosis of diabetes. Acta Paediatr. 2000;89:46\u201351.","journal-title":"Acta Paediatr"},{"key":"2248_CR12","first-page":"155","volume":"23","author":"JC Ongagna","year":"1997","unstructured":"Ongagna JC, Levy-Marchal C. Sensitivity at diagnosis of combined beta-cell autoantibodies in insulin-dependent diabetic children. French Registry of IDDM in Children Study Group. Diabetes Metab. 1997;23:155\u201360.","journal-title":"Diabetes Metab"},{"key":"2248_CR13","doi-asserted-by":"publisher","first-page":"248","DOI":"10.2337\/dc18-1507","volume":"42","author":"J Virostko","year":"2019","unstructured":"Virostko J, Williams J, Hilmes M, Bowman C, Wright JJ, Du L, et al. Pancreas volume declines during the first year after diagnosis of type 1 diabetes and exhibits altered diffusion at disease onset. Diabetes Care. 2019;42:248\u201357.","journal-title":"Diabetes Care"},{"key":"2248_CR14","doi-asserted-by":"crossref","unstructured":"Toots M, Seppa K, Jagom\u00e4e T, Koppel T, Pallase M, Heinla I, et al. Preventive treatment with liraglutide protects against development of glucose intolerance in a rat model of Wolfram syndrome. Sci Rep. 2018;8.","DOI":"10.1038\/s41598-018-28314-z"},{"key":"2248_CR15","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1007\/s00125-018-4679-y","volume":"61","author":"M Kondo","year":"2018","unstructured":"Kondo M, Tanabe K, Amo-Shiinoki K, Hatanaka M, Morii T, Takahashi H, et al. Activation of GLP-1 receptor signalling alleviates cellular stresses and improves beta cell function in a mouse model of Wolfram syndrome. Diabetologia. 2018;61:2189\u2013201.","journal-title":"Diabetologia"},{"key":"2248_CR16","doi-asserted-by":"crossref","unstructured":"Scully KJ, Wolfsdorf JI. Efficacy of GLP-1 agonist therapy in autosomal dominant WFS1-related disorder: a case report. Horm Res Paediatr. 2020;1\u20136.","DOI":"10.1159\/000510852"},{"key":"2248_CR17","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/ajmg.a.35229","volume":"158A","author":"MG Butler","year":"2012","unstructured":"Butler MG, Dagenais SL, Garcia-Perez JL, Brouillard P, Vikkula M, Strouse P, et al. Microcephaly, intellectual impairment, bilateral vesicoureteral reflux, distichiasis, and glomuvenous malformations associated with a 16q24.3 contiguous gene deletion and a Glomulin mutation. Am J Med Genet A. 2012;158A:839\u201349.","journal-title":"Am J Med Genet A"},{"key":"2248_CR18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/jmedgenet-2012-101288","volume":"50","author":"GR Handrigan","year":"2013","unstructured":"Handrigan GR, Chitayat D, Lionel AC, Pinsk M, Vaags AK, Marshall CR, et al. Deletions in 16q24.2 are associated with autism spectrum disorder, intellectual disability and congenital renal malformation. J Med Genet. 2013;50:163\u201373.","journal-title":"J Med Genet"},{"key":"2248_CR19","unstructured":"UCSC Genomic Institute. UCSC Genomic Institute (University of California Santa Cruz). UCSC Genome Browser on Human Feb.2009 (GR37\/hg 19) Assembly-chr16:87152792-87845741. https:\/\/genome.ucsc.edu\/cgi-bin\/hgTracks?db=hg19&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=chr16%3A87152792%2D87845741&hgsid=948807615_BA0atwvAXAUEOzrYkusmP8ZsgpOA."},{"key":"2248_CR20","unstructured":"Mansour S, Brice GW, Jeffery S, Mortimer P. GeneReviews\u00ae\u2014Lymphedema-Distichiasis Syndrome. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1457\/."},{"key":"2248_CR21","unstructured":"Tissue expression of FOXC2\u2014Summary\u2014The Human Protein Atlas. https:\/\/www.proteinatlas.org\/ENSG00000176692-FOXC2\/tissue."},{"key":"2248_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13073-019-0656-4","volume":"11","author":"JH Wong","year":"2019","unstructured":"Wong JH, Shigemizu D, Yoshii Y, Akiyama S, Tanaka A, Nakagawa H, et al. Identification of intermediate-sized deletions and inference of their impact on gene expression in a human population. Genome Med. 2019;11:44. https:\/\/doi.org\/10.1186\/s13073-019-0656-4.","journal-title":"Genome Med"},{"key":"2248_CR23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.tig.2016.01.003","volume":"32","author":"DG Lupi\u00e1\u00f1ez","year":"2016","unstructured":"Lupi\u00e1\u00f1ez DG, Spielmann M, Mundlos S. Breaking TADs: how alterations of chromatin domains result in disease. Trends Genet. 2016;32:225\u201337.","journal-title":"Trends Genet"},{"key":"2248_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/19491034.2017.1389365","volume":"9","author":"AS Hansen","year":"2018","unstructured":"Hansen AS, Cattoglio C, Darzacq X, Tjian R. Recent evidence that TADs and chromatin loops are dynamic structures. Nucleus. 2018;9:20\u201332.","journal-title":"Nucleus"},{"key":"2248_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41525-020-00162-9","volume":"5","author":"LA Jolly","year":"2020","unstructured":"Jolly LA, Parnell E, Gardner AE, Corbett MA, P\u00e9rez-Jurado LA, Shaw M, et al. Missense variant contribution to USP9X-female syndrome. NPJ Genom Med. 2020;5:1\u201311.","journal-title":"NPJ Genom Med"},{"key":"2248_CR26","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ajhg.2015.12.015","volume":"98","author":"MRF Reijnders","year":"2016","unstructured":"Reijnders MRF, Zachariadis V, Latour B, Jolly L, Mancini GM, Pfundt R, et al. De novo loss-of-function mutations in USP9X cause a female-specific recognizable syndrome with developmental delay and congenital malformations. Am J Hum Genet. 2016;98:373\u201381.","journal-title":"Am J Hum Genet"},{"key":"2248_CR27","doi-asserted-by":"crossref","unstructured":"Vaxillaire M, Bonnefond A, Liatis S, Ben Salem Hachmi L, Jotic A, Boissel M, et al. Monogenic diabetes characteristics in a transnational multicenter study from Mediterranean countries. Diabetes Res Clin Pract. 2020;108553.","DOI":"10.1016\/j.diabres.2020.108553"},{"key":"2248_CR28","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"2248_CR29","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248\u20139.","journal-title":"Nat Methods"},{"key":"2248_CR30","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nmeth.2890","volume":"11","author":"JM Schwarz","year":"2014","unstructured":"Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods. 2014;11:361\u20132.","journal-title":"Nat Methods"},{"key":"2248_CR31","doi-asserted-by":"crossref","unstructured":"Wang Y, Song F, Zhang B, Zhang L, Xu J, Kuang D, et al. The 3D Genome Browser: a web-based browser for visualizing 3D genome organization and long-range chromatin interactions. Genome Biol. 2018;19.","DOI":"10.1186\/s13059-018-1519-9"},{"key":"2248_CR32","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature19847","volume":"538","author":"H Won","year":"2016","unstructured":"Won H, de la Torre-Ubieta L, Stein JL, Parikshak NN, Huang J, Opland CK, et al. Chromosome conformation elucidates regulatory relationships in developing human brain. Nature. 2016;538:523\u20137.","journal-title":"Nature"},{"key":"2248_CR33","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1002\/ajmg.a.36569","volume":"164","author":"AH Seeley","year":"2014","unstructured":"Seeley AH, Durham MA, Micale MA, Wesolowski J, Foerster BR, Martin DM. Macrocerebellum, epilepsy, intellectual disability, and gut malrotation in a child with a 16q24.1\u2013q24.2 contiguous gene deletion. Am J Med Genet A. 2014;164:2062\u20138. https:\/\/doi.org\/10.1002\/ajmg.a.36569.","journal-title":"Am J Med Genet A"},{"key":"2248_CR34","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1111\/jcmm.16223","volume":"25","author":"X Shi","year":"2021","unstructured":"Shi X, Han X, Cao Y, Li C, Cao Y. ZCCHC14 regulates proliferation and invasion of non\u2013small cell lung cancer through the MAPK-P38 signalling pathway. J Cell Mol Med. 2021;25:1406\u201314.","journal-title":"J Cell Mol Med"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02248-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02248-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02248-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T18:05:17Z","timestamp":1646071517000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02248-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,28]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2248"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02248-2","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,28]]},"assertion":[{"value":"25 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed were in accordance with the ethical standards of the institutional committee and with the 1964 Helsinki declaration and its later amendments. Written informed consent from patients\/participants and their parents\/legal guardians has been obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent from the parents\/legal guardians of the patients\/participants was obtained for the publication of their data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing financial interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}